Navigation Links
Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD
Date:10/24/2007

00-755-5560 and ask for Customer Service.

About COPD

COPD refers to a number of chronic lung disorders in which the airways to the lungs become narrowed and breathing becomes increasingly difficult. The most common forms of COPD are chronic bronchitis and emphysema, and many patients suffer from a combination of the two diseases.

COPD is the fourth leading cause of death in America, behind heart disease, cancer and stroke. Twelve million Americans have been diagnosed with COPD and at least another 12 million have symptoms but are not diagnosed. COPD is not well understood or recognized -- most Americans have not heard of it, not even those who may be living with the condition. The most common cause of COPD is cigarette smoking, which is responsible for an estimated 80 to 90 percent of COPD cases. Estimates of the total incidence of COPD in America range from 24 to 30 million.

About Nebulization

Of the three types of devices used to deliver bronchodilators -- nebulizers, metered-dose inhalers, and dry powder inhalers -- nebulizers require no special technique or coordination, as the medication is converted into a fine mist that the patient inhales through a mouthpiece or face-mask while breathing naturally. Because nebulization is an easy, effective, and thorough method of delivering medicine directly into the lungs, many COPD patients ask for it, particularly as their symptoms worsen.

With Perforomist(TM) Inhalation Solution, nebulization may become a more widely used treatment option for many COPD patients at earlier treatment stages who could benefit from twice-daily maintenance dosing of a nebulized LABA such as Perforomist(TM) Inhalation Solution. For example, this new COPD treatment may be a valuable clinical option for many patients who are not adequately controlled with short-acting bronchodilators.

About Dey, L.P.

Dey, L.P., a subsidiary of Mylan Inc. (NYSE:

SOURCE Dey, L.P.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
9. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... , Aug. 19, 2014  The Alabama Supreme Court, in ... can sue drug makers who mislead doctors into believing that ... The case is Weeks v. Wyeth, and the decision came ... that same case last year. Heninger Garrison Davis attorneys ... patient in the case, Danny Weeks . ...
(Date:8/19/2014)... , Aug. 19, 2014 Minimally Invasive ... medical device company, announced today that Mitsubishi Corporation ... and robotic visualization system in Japan ... sale in Japan in the ... also the exclusive distributor for Karl Storz GMBH & ...
(Date:8/19/2014)... Aug. 19, 2014  As power morcellator lawsuits ... Bernstein Liebhard LLP notes that women in need ... a number of options that do not involve ... According to a report published by The Wall ... options include a mini-laparotomy and vaginal hysterectomy. Non-surgical ...
Breaking Medicine Technology:Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 2Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 3Heninger Garrison Davis Clients To Get Their Day in Court Against Brand Drug Companies 4Minimally Invasive Devices and Mitsubishi Medical Japan Forge Exclusive Distribution Agreement 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 3
... , Jan. 25 Curemark, LLC , ( www.curemark.com ... neurological diseases, announced that the company is now enrolling patients in Phase ... the country.  The sites are: , Mount Sinai School of Medicine, ... University of Texas, Houston Indiana University, ...
... , MELVILLE, N.Y. , Jan. 25 ... the largest distributor of health care products and services to office-based ... Bradley T. Sheares , Ph.D. to the Company,s Board of Directors. ... a wealth of health care experience to the Henry Schein Board. ...
Cached Medicine Technology:Curemark Enrolling Patients In Phase III Autism Trials At Ten Sites 2Curemark Enrolling Patients In Phase III Autism Trials At Ten Sites 3Curemark Enrolling Patients In Phase III Autism Trials At Ten Sites 4Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors 2Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors 3Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors 4Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors 5
(Date:8/20/2014)... B. E. Smith, the only full-service leadership solutions ... to lead a national chief operating officer ... Ore. The top executive search firm in ... more than 900 healthcare executives into organizations. , ... healthcare organization serving a population of more than 35,000 ...
(Date:8/20/2014)... Hope For The Warriors® is excited to announce ... in Washington, DC on Thursday, October 2, 2014 at ... the courage of our wounded service members, their families, ... Got Heart, Give Hope® Celebration will benefit Hope For ... sense of self, restoring the family unit, and restoring ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Inc. ... year on its 33rd annual Inc. 500|5000, an ... The list represents the most comprehensive look at ... entrepreneurs. Companies such as Yelp, Pandora, Timberland, Dell, ... names gained early exposure as members of the ...
(Date:8/20/2014)... Atlanta, GA (PRWEB) August 20, 2014 ... Data to healthcare, Jvion successfully predicted stage iii ... levels that, in some situations, approached 90%. A ... never been achieved in commercial or academic settings. ... and prevent all types of hospital-acquired conditions to ...
(Date:8/20/2014)... Ticketability.com has Theresa Caputo tickets for ... well-known medium has been thrilling many with her amazing ... cities, with tickets becoming available August 15. , Among ... Albany, Baltimore, Trenton, Erie, Buffalo, Philadelphia, Charlotte, Houston, New ... Diego. The medium’s fans can obtain Theresa Caputo tour ...
Breaking Medicine News(10 mins):Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 2Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 3Health News:Hope For The Warriors Announces Got Heart, Give Hope Celebration in Washington, DC 2Health News:Etransmedia Makes Exclusive List for the Eighth Consecutive Year in Inc. Magazine 2Health News:Etransmedia Makes Exclusive List for the Eighth Consecutive Year in Inc. Magazine 3Health News:Jvion Achieves Benchmark Accuracy in Pressure Ulcer Prediction 2Health News:Theresa Caputo Tour Tickets for Sale at Ticketability.com Cause a Buying Frenzy Among Customers Over Their Offering of Deeply Discounted Seats 2
... treatment mainstay for prostate cancer puts men at increased ... large observational study published in the// Sept. 20 Journal ... have high five-year survival rates, but they also have ... study author Nancy Keating, MD, MPH, assistant professor of ...
... Chile announced a tax on airline tickets to raise ... who cannot afford them//. ,Representatives from the five ... Ignacio Lula da Silva of Brazil, were present for ... Annan and former US President Bill Clinton also attended. ...
... are almost twice as likely to attempt suicide as non-Maori ... than other New Zealanders. ,The survey conducted by the ... the prevalence of mental disorders among different ethnic groups in ... including 2600 Maori. ,It was found that thirty percent ...
... Recent studies have revealed that increased levels of ... events// in healthy women according to Boston-based investigators. ... screening of lipoprotein(a) in the population as a ... with cardiovascular risk. Besides that most lipid-correcting therapies ...
... tested as an anticancer agent to treat breast cancer, supports ... ,Duchene muscular dystrophy is a disease characterized by ... According to earlier studies, the functional decline of "dystrophic" ... fiber size. ,The recent study conducted by Dr. ...
... (China): More than 200 children were taken ill after eating ... ,The 223 students were admitted to a hospital and are ... ,Students of Dianshi Town High School began reporting symptoms ... at their school Monday and were immediately hopitalised. ...
Cached Medicine News:Health News:Prostate Cancer Treatment Increases Risk of Diabetes and Heart Disease 2Health News:High lipoprotein Levels in women Linked to Cardiovascular Risk 2Health News:Anti-cancer drug may treat muscular dystrophy 2
... The HSV Non-Typing ASR contains primers and ... a 92 bp region of the HSV Type ... requires an instrument that can detect a FAM ... The Cepheid Analyte Specific Reagent* (ASR) program is ...
... compact system is perfect for the office, ... cost effective microhematocrits are required. Featuring a ... offers a range of important benefits: - ... Meets NCCLS standards - Read tubes in ...
... Palomar systems deliver pulsed light over ... multiple power spikes (which may damage skin) ... Cooling technology sends a chilled water supply ... sapphire tip, which is cooled to as ...
Used to provide drainage of urine from the bladder. All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open packages. Inte...
Medicine Products: